Oxidative stress and its role in female infertility and assisted reproduction: Clinical implications

International Journal of Fertility and Sterility

Volumn 2, Issue 4, 2009, Pages 147-164

  Gupta, Sajal ^a   Malhotra, Neena ^a   Sharma, Dipika ^a   Chandra, Anjali ^a   Ashok, Agarwal ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Antioxidants; Assisted reproductive techniques; Infertility; Oxidative stress; Reactive oxygen species

Indexed keywords

ALPHA TOCOPHEROL; AMINE OXIDASE (FLAVIN CONTAINING); ANTIOXIDANT; ASCORBIC ACID; CATALASE; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR; FOLIC ACID; GLUTAREDOXIN; GLUTATHIONE PEROXIDASE; HOMOCYSTEINE; HYDROETHIDINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MALONALDEHYDE; METALLOPROTEINASE; METFORMIN; NITRIC OXIDE; PROGESTERONE; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN SYNTHASE; PYRIDOXINE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; ROSIGLITAZONE; SOMATOMEDIN; SOMATOMEDIN B; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNINDEXED DRUG;

ANTIOXIDANT ACTIVITY; APOPTOSIS; BIRTH; BLASTOCYST; BLEEDING; CELL DAMAGE; CELL PROTECTION; CHEMOLUMINESCENCE; CHORIOAMNIONITIS; CRYOPRESERVATION; CULTURE MEDIUM; DNA DAMAGE; ELECTRON PARAMAGNETIC SPIN TRAP RESONANACE; EMBRYO CULTURE; EMBRYO DEVELOPMENT; ENDOMETRIOSIS; ENDOMETRIUM; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMALE INFERTILITY; FERTILITY; FERTILIZATION; FERTILIZATION IN VITRO; FETUS DISTRESS; FETUS OUTCOME; GAMETE; HOMEOSTASIS; HUMAN; HYDROSALPINGEAL FLUID; HYPERHOMOCYSTEINEMIA; HYPEROXIA; IN VITRO MATURATION OF OOCYTE; INCUBATION TIME; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; LABOR INDUCTION; LEUKOCYTE ACTIVATION; LIGHT EXPOSURE; LIPID PEROXIDATION; MACROPHAGE ACTIVATION; MENSTRUAL CYCLE; MENSTRUATION; MOLECULAR PROBE; NONHUMAN; OOCYTE MATURATION; OVARY FOLLICLE FLUID; OVARY POLYCYSTIC DISEASE; OVULATION; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; OXYGEN TENSION; PLACENTA; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANCY RATE; PREMATURE LABOR; PROTEIN EXPRESSION; RECURRENT ABORTION; REVIEW; SISTER CHROMATID EXCHANGE; SMOKING; SPECTROPHOTOMETRY; SPERMATOZOON; VAGINAL DELIVERY;

EID: 67649415985     PISSN: 2008076X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (186)

1. Warren JS, Johnson KJ, Ward PA. Oxygen radicals in cell injury and cell death. Pathol Immunopathol Res. 1987; 6: 301-15.
2. Halliwell BJ, Gutteridge M. Free radicals and antioxidant protection: mechanisms and significance in toxicology and disease. Hum Toxicol. 1988; 7: 7-13.
3. Agarwal A, Gupta S, Sikka S. The role of free radicals and antioxidants in reproduction. Curr Opin Obstet Gynecol. 2006; 18: 325-332.
4. Agarwal A, Nallella KP, Allamaneni SS, Said TM. Role of antioxidants in treatment of male infertility: an overview of the literature. Reprod Biomed Online. 2004; 8: 616-627.
5. Agarwal A, Saleh RA, Bedaiwy MA. Role of reactive oxygen species in the pathophysiology of human reproduction. Fertil Steril. 2003; 79: 829-843.
6. Alpay Z, Saed GM, Diamond MP. Female infertility and free radicals: potential role in adhesions and endometriosis. J Soc Gynecol Investig. 2006; 13: 390-398.
7. Guerin P, El Mouatassim S, Menezo Y. Oxidative stress and protection against reactive oxygen species in the pre-implantation embryo and its surroundings. Hum Reprod Update. 2001; 7: 175-189.
8. Lagod L, Paszkowski T, Sikorski R, Rola R. The antioxidant-prooxidant balance in pregnancy complicated by spontaneous abortion. Ginekol Pol. 2001; 72: 1073-1078.
9. Agarwal A, Gupta S, Sharma RK. Role of oxidative stress in female reproduction. Reprod Biol Endocrinol. 2005; 3: 28.
10. Agarwal A, Gupta S, Sharma R. Oxidative stress and its implications in female infertility - a clinician's perspective. Reprod Biomed Online. 2005; 11: 641-650.
11. Dong M, Shi Y, Cheng Q, Hao M. Increased nitric oxide in peritoneal fluid from women with idiopathic infertility and endometriosis. J Reprod Med. 2001; 46: 887-891.
12. Pierce JD, Cackler AB, Arnett MG. Why should you care about free radicals? RN. 2004; 67: 38-42
13. Ohl J, Lefebvre-Maunoury G, Wittemer C, Nisand G, Laurent MC, Hoffmann P. Nitric oxide donors for patients undergoing IVF. A prospective, double-blind, randomized, placebo-controlled trial. Hum Reprod. 2002; 17: 2615-2620.
14. Rosselli M, Keller PJ, Dubey RK. Role of nitric oxide in the biology, physiology and pathophysiology of reproduction. Hum Reprod Update. 1998; 4: 3-24.
15. Agarwal A, Allamaneni SS. Role of free radicals in female reproductive diseases and assisted reproduction. Reprod Biomed Online. 2004; 9: 338-347.
16. El Mouatassim S, Guerin P, Menezo Y. Expression of genes encoding antioxidant enzymes in human and mouse oocytes during the final stages of maturation. Mol Hum Reprod. 1999; 5: 720-725.
17. Sharma A. Role of reactive oxygen species in gynecologic diseases. Reprod Med Bio. 2004; 3: 177-199.
18. Chew BP, Holpuch DM, O'Fallon JV. Vitamin A and beta-carotene in bovine and porcine plasma, liver, corpora lutea, and follicular fluid. J Dairy Sci. 1984; 67: 1316-1322.
19. Michiels C, Raes M, Toussaint O, Remacle J. Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress. Free Radic Biol Med. 1994; 17: 235-248.
20. Luberda Z. The role of glutathione in mammalian gametes. Reprod Biol. 2005; 5: 5-17.
21. Alvarez JG, Storey BT. Taurine, hypotaurine, epinephrine and albumin inhibit lipid peroxidation in rabbit spermatozoa and protect against loss of motility. Biol Reprod. 1983; 29: 548-555.
22. Guerin P, Menezo Y. Hypotaurine and taurine in gamete and embryo environments: de novo synthesis via the cysteine sulfinic acid pathway in oviduct cells. Zygote. 1995; 3: 333-343.
23. Menezo YJ, Hazout A, Panteix G, Robert F, Rollet J, Cohen-Bacrie P, et al. Antioxidants to reduce sperm DNA fragmentation: an unexpected adverse effect. Reprod Biomed Online. 2007; 14: 418-421.
24. Fu LX, Kirkeboen KA, Liang QM, Sjogren KG, Hjalmarson A, Ilebekk A. Free radical scavenging enzymes and G protein mediated receptor signalling systems in ischaemically preconditioned porcine myocardium. Cardiovasc Res. 1993; 27: 612-616.
25. Gardiner CS, Reed DJ. Synthesis of glutathione in the preimplantation mouse embryo. Arch Biochem Biophys. 1995; 318: 30-36.
26. de Bruin JP, Dorland M, Spek ER, Posthuma G, van Haaften M, Looman CW, et al. Ultrastructure of the resting ovarian follicle pool in healthy young women. Biol Reprod. 2002; 66: 1151-1160.
27. Myatt L, Cui X. Oxidative stress in the placenta. Histochem Cell Biol. 2004; 122: 369-382.
28. Fainaru O, Almog B, Pinchuk I, Kupferminc MJ, Lichtenberg D, Many A. Active labour is associated with increased oxidisibility of serum lipids ex vivo. Bjog. 2002; 109: 938-941.
29. Mocatta TJ, Winterbourn CC, Inder TE, Darlow BA. The effect of gestational age and labour on markers of lipid and protein oxidation in cord plasma. Free Radic Res. 2004; 38: 185-191.
30. Wall PD, Pressman EK, Woods JR. Preterm premature rupture of the membranes and antioxidants: the free radical connection. J Perinat Med. 2002; 30: 447-457.
31. Pressman EK, Cavanaugh JL, Mingione M, Norkus EP, Woods JR. Effects of maternal antioxidant supplementation on maternal and fetal antioxidant levels: a randomized, double-blind study. Am J Obstet Gynecol. 2003; 189: 1720-1725.
32. Mant JW, Vessey MP. Ovarian and endometrial cancers. Cancer Surv. 1994; 19-20: 287-307.
33. Behrman HR, Kodaman PH, Preston SL, Gao S. Oxidative stress and the ovary. J Soc Gynecol Investig. 2001; 8: 40-42.
34. Murdoch WJ, Martinchick JF. Oxidative damage to DNA of ovarian surface epithelial cells affected by ovulation: carcinogenic implication and chemoprevention. Exp Biol Med (Maywood). 2004; 229: 546-552.
35. Ray SD, Lam TS, Rotollo JA, Phadke S, Patel C, Dontabhaktuni A, et al. Oxidative stress is the master operator of drug and chemically-induced programmed and unprogrammed cell death: Implications of natural antioxidants in vivo. Biofactors. 2004; 21: 223-232.
36. Ishikawa M. Oxygen radicals-superoxide dismutase system and reproduction medicine. Nippon Sanka Fujinka Gakkai Zasshi. 1993; 45: 842-848.
37. Jozwik M, Wolczynski S, Szamatowicz M. Oxidative stress markers in preovulatory follicular fluid in humans. Mol Hum Reprod. 1999; 5: 409-413.
38. Suzuki T, Sugino N, Fukaya T, Sugiyama S, Uda T, Takaya R, et al. Superoxide dismutase in normal cycling human ovaries: immunohistochemical localization and characterization. Fertil Steril. 1999; 72: 720-726.
39. Vega M, Johnson MC, Diaz HA, Urrutia LR, Troncoso JL, Devoto L. Regulation of human luteal steroidogenesis in vitro by nitric oxide. Endocrine. 1998; 8: 185-191.
40. Sugino N, Takiguchi S, Kashida S, Karube A, Nakamura A, Kato H. Superoxide dismutase expression in the human corpus luteum during the menstrual cycle and in early pregnancy. Mol Hum Reprod. 2000; 6: 19-25.
41. Al-Gubory KH, Bolifraud P, Germain G, Nicole A, Ceballos-Picot I. Antioxidant enzymatic defence systems in sheep corpus luteum throughout pregnancy. Reproduction. 2004; 128: 767-774.
42. Bisseling JG, Knapen MF, Goverde HJ, Mulder TP, Peters WH, Willemsen WN, et al. Glutathione S-transferases in human ovarian follicular fluid. Fertil Steril. 1997; 68: 907-911.
43. Paszkowski T, Traub AI, Robinson SY, McMaster D. Selenium dependent glutathione peroxidase activity in human follicular fluid. Clin Chim Acta. 1995; 236: 173-180.
44. Garcia-Pardo L, Granados MD, Gaytan F, Padilla CA, Martinez-Galisteo E, Morales C, et al. Immunolocalization of glutaredoxin in the human corpus luteum. Mol Hum Reprod. 1999; 5: 914-919.
45. Tranquilli AL, Bezzeccheri V, Giannubilo SR. Scagnoli C, Mazzanti L, Garzetti GG. Amniotic vascular endothelial growth factor (VEGF) and nitric oxide (NO) in women with subsequent preeclampsia. Eur J Obstet Gynecol Reprod Biol. 2004; 113: 17-20.
46. Takagi Y, Nikaido T, Toki T, Kita N, Kanai M, Ashida T, et al. Levels of oxidative stress and redox-related molecules in the placenta in preeclampsia and fetal growth restriction. Virchows Arch. 2004; 444: 49-55.
47. Harma M, Kocyigit A. Comparison of protein carbonyl and total plasma thiol concentrations in patients with complete hydatidiform mole with those in healthy pregnant women. Acta Obstet Gynecol Scand. 2004; 83: 857-860.
48. Harma M, Kocyigit A, Demir N. Role of plasma nitric oxide in complete hydatidiform mole. Eur J Gynaecol Oncol. 2004; 25: 333-335.
49. Harma M, Erel O. Increased oxidative stress in patients with hydatidiform mole. Swiss Med Wkly. 2003; 133: 563-566.
50. Loeken MR. Free radicals and birth defects. J Matern Fetal Neonatal Med. 2004; 15: 6-14.
51. Yang HW, Hwang KJ, Kwon HC, Kim HS, Choi KW, Oh KS. Detection of reactive oxygen species (ROS) and apoptosis in human fragmented embryos. Hum Reprod. 1998; 13: 998-1002.
52. Holthe MR, Staff AC, Berge LN, Lyberg T. Leukocyte adhesion molecules and reactive oxygen species in preeclampsia. Obstet Gynecol. 2004; 103: 913-922.
53. Lee KS, Joo BS, Na YJ, Yoon MS, Choi OH, Kim W. Relationships between concentrations of tumor necrosis factor-alpha and nitric oxide in follicular fluid and oocyte quality. J Assist Reprod Genet. 2000; 17: 222-228.
54. Sabatini L, Wilson C, Lower A, Al-Shawaf T, Grudzinskas JG. Superoxide dismutase activity in human follicular fluid after controlled ovarian hyperstimulation in women undergoing in vitro fertilization. Fertil Steril. 1999; 72: 1027-1034.
55. Cetica PD, Pintos LN, Dalvit GD, Beconi MT. Antioxidant enzyme activity and oxidative stress in bovine oocyte in vitro maturation. IUBMB Life. 2001; 51: 57-64.
56. Tamate K, Sengoku K, Ishikawa M. The role of superoxide dismutase in the human ovary and fallopian tube. J Obstet Gynaecol. 1995; 21: 401-409.
57. Shaamash AH, Zakhari MM. Increased serum levels of nitric oxide metabolites among users: a possible role in progestin-induced bleeding. Hum Reprod. 2004.
58. Osborn BH, Haney AF, Misukonis MA, Weinberg JB. Inducible nitric oxide synthase expression by peritoneal macrophages in endometriosis-associated infertility. Fertil Steril. 2002; 77: 46-51.
59. Seino T, Saito H, Kaneko T, Takahashi T, Kawachiya S, Kurachi H. Eight-hydroxy-2′-deoxyguanosine in granulosa cells is correlated with the quality of oocytes and embryos in an in vitro fertilization-embryo transfer program. Fertil Steril. 2002; 77: 1184-1190.
60. Sugino N, Karube-Harada A, Sakata A, Takiguchi S, Kato H. Nuclear factor-kappa B is required for tumor necrosis factor-alpha-induced manganese superoxide dismutase expression in human endometrial stromal cells. J Clin Endocrinol Metab. 2002; 87: 3845-3850.
61. Sugino N, Karube-Harada A, Taketani T, Sakata A, Nakamura Y. Withdrawal of ovarian steroids stimulates prostaglandin F2alpha production through nuclear factorkappaB activation via oxygen radicals in human endometrial stromal cells: potential relevance to menstruation. J Reprod Dev. 2004; 50,: 215-225.
62. Sugino N. The role of oxygen radical-mediated signaling pathways in endometrial function. Placenta. 2008; 28 Supple A: 133-136.
63. Hickey M, Krikun G, Kodaman P, Schatz F, Carati C, Lockwood CJ. Long-term progestin-only contraceptives result in reduced endometrial blood flow and oxidative stress. J Clin Endocrinol Metab. 2006; 91: 3633-3638.
64. Sikkema JM, van Rijn BB, Franx A, Bruinse HW, de Roos R, Stroes ES, et al. Placental superoxide is increased in pre-eclampsia. Placenta. 2001; 22: 304-308.
65. Little RE, Gladen BC. Levels of lipid peroxides in uncomplicated pregnancy: a review of the literature. Reprod Toxicol. 1999; 13: 347-352.
66. Diamant S, Kissilevitz R, Diamant Y. Lipid peroxidation system in human placental tissue: general properties and the influence of gestational age. Biol Reprod. 1980; 23: 776-781.
67. Ishihara M. Studies on lipoperoxide of normal pregnant women and of patients with toxemia of pregnancy. Clin Chim Acta. 1978; 84: 1-9.
68. Ishihara O, Hayashi M, Osawa H, Kobayashi K, Takeda S, Vessby B, et al. Isoprostanes, prostaglandins and tocopherols in pre-eclampsia, normal pregnancy and non-pregnancy. Free Radic Res. 2004; 38: 913-918.
69. Sacks GP, Studena K, Sargent K, Redman CW. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol. 1998; 179: 80-86.
70. Wiktor H, Kankofer M, Schmerold I, Dadak A, Lopucki M, Niedermuller H. Oxidative DNA damage in placentas from normal and pre-eclamptic pregnancies. Virchows Arch. 2004; 445: 74-78.
71. Jauniaux E, Hempstock J, Greenwold N, Burton GJ. Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies. Am J Pathol. 2003; 162: 115-125.
72. Buhimschi IA, Buhimschi CS. Pupkin M, Weiner CP. Beneficial impact of term labor: nonenzymatic antioxidant reserve in the human fetus. Am J Obstet Gynecol. 2003; 189: 181-188.
73. Saugstad OD. Bronchopulmonary dysplasia-oxidative stress and antioxidants. Semin Neonatol. 2003; 8: 39-49.
74. Frosali S, Di Simplicio P, Perrone S, Di Giuseppe D, Longini M, Tanganelli D, et al. Glutathione recycling and antioxidant enzyme activities in erythrocytes of term and preterm newborns at birth. Biol Neonate. 2004; 85: 188-194.
75. Dennery PA. Role of redox in fetal development and neonatal diseases. Antioxid Redox Signal. 2004; 6: 147-153.
76. Banerjee S, Smallwood A, Moorhead J, Chambers AE, Papageorghiou A, Campbell S, et al. Placental expression of IFN-{gamma} and its receptor IFN-{gamma} R2 fail to switch from early hypoxic to late normotensive development in pre-eclampsia. J Clin Endocrinol Metab. 2004.
77. Aydin S, Benian A, Madazli R, Uludag S, Uzun H, Kaya S. Plasma malondialdehyde, superoxide dismutase, sE-selectin, fibronectin, endothelin-1 and nitric oxide levels in women with preeclampsia. Eur J Obstet Gynecol Reprod Biol. 2004; 113: 21-25.
78. Gupta P, Narang M, Banerjee BD, Basu S. Oxidative stress in term small for gestational age neonates born to undernourished mothers: a case control study. BMC Pediatr. 2004; 4: 14.
79. Orhan H, Onderoglu L, Yucel A, Sahin G. Circulating biomarkers of oxidative stress in complicated pregnancies. Arch Gynecol Obstet. 2003; 267: 189-195.
80. Lappas M, Permezel M, Rice GE. N-Acetyl-cysteine inhibits phospholipid metabolism, proinflammatory cytokine release, protease activity, and nuclear factor-kappaB deoxyribonucleic acid-binding activity in human fetal membranes in vitro. J Clin Endocrinol Metab. 2003; 88: 1723-1729.
81. Temma K, Shimoya K, Zhang Q, Kimura T, Wasada K, Kanzaki T, et al. Effects of 4-hydroxy-2-nonenal, a marker of oxidative stress, on the cyclooxygenase-2 of human placenta in chorioamnionitis. Mol Hum Reprod. 2004; 10: 167-171.
82. Buhimschi IA, Kramer WB, Buhimschi CS, Thompson LP, Weiner CP. Reduction-oxidation (redox) state regulation of matrix metalloproteinase activity in human fetal membranes. Am J Obstet Gynecol. 2000; 182: 458-464.
83. Dani C, Cecchi A, Bertini G. Role of oxidative stress as physiopathologic factor in the preterm infant. Minerva Pediatr. 2004; 56: 381-394.
84. Liu BY, Wang CC, Lau TK, Chu CY, Phil M, Pang CP, et al. Meconium-stained liquor during labor is associated with raised neonatal cord blood 8-iso-prostaglandin F2alpha concentration. Am J Obstet Gynecol. 2005; 192: 289-294.
85. Djordjevic A, Spasic S, Jovanovic-Galovic A, Djordjevic R, Grubor-Lajsic G. Oxidative stress in diabetic pregnancy: SOD, CAT and GSH-Px activity and lipid peroxidation products. J Matern Fetal Neonatal Med. 2004; 16: 367-372.
86. Peuchant E, Brun JL, Rigalleau V, Dubourg L, Thomas MJ, Daniel JY, et al. Oxidative and antioxidative status in pregnant women with either gestational or type 1 diabetes. Clin Biochem. 2004; 37: 293-298.
87. Wender-Ozegowska E, Kozlik J, Biczysko R, Ozegowski S. Changes of oxidative stress parameters in diabetic pregnancy. Free Radic Res. 2004; 38: 795-803.
88. Park E, Wagenbichler P, Elmadfa I. Effects of multivitamin/mineral supplementation, at nutritional doses, on plasma antioxidant status and DNA damage estimated by sister chromatid exchanges in lymphocytes in pregnant women. Int J Vitam Nutr Res. 1999; 69: 396-402.
89. Rai R, Regan L. Recurrent miscarriage. Lancet. 2006; 368: 601-611.
90. Stephenson M, Kutteh W. Evaluation and management of recurrent early pregnancy loss. Clin Obstet Gynecol. 2007; 50: 132-145.
91. Cramer DW, Wise LA. The epidemiology of recurrent pregnancy loss. Semin Reprod Med. 2000; 18: 331-339.
92. Gupta S, Agarwal A, Banerjee J, Alvarez JG. The role of oxidative stress in spontaneous abortion and recurrent pregnancy loss: a systematic review. Obstet Gynecol Surv, 2007; 62: 335-347; quiz 353-354.
93. Jauniaux E, Watson AL, Hempstock J, Bao YP, JN, Skepper JN, Burton GJ. Onset of maternal arterial blood flow and placental oxidative stress. A possible factor in human early pregnancy failure. Am J Pathol. 2000; 157: 2111-2122.
94. Burton GJ, Hempstock J, Jauniaux E. Oxygen, early embryonic metabolism and free radical-mediated embryopathies. Reprod Biomed Online. 2003; 6: 84-96.
95. Fait V, Sela S, Ophir E, Kreutzer H, Shnaider O, Perri A, et al. Peripheral polymorphonuclear leukocyte priming contributes to oxidative stress in early pregnancy. J Soc Gynecol Investig. 2005; 12: 46-49.
96. Safronova VG, Matveeva NK, Avkhacheva NV, Sidel'nikova VM, Van'ko LV, Sukhikh GT. Changes in regulation of oxidase activity of peripheral blood granulocytes in women with habitual abortions. Bull Exp Biol Med. 2003; 136: 257-260.
97. Ferro D, Iuliano L, Violi F, Valesini G, Conti F. Antioxidant treatment decreases the titer of circulating anticardiolipin antibodies: comment on the article by Sambo et al. Arthritis Rheum. 2002; 46: 3110-3112.
98. Simsek M, Naziroglu M, Simsek H, Cay M, Aksakal M, Kumru S. Blood plasma levels of lipoperoxides, glutathione peroxidase, beta carotene, vitamin A and E in women with habitual abortion. Cell Biochem Funct. 1998; 16: 227-231.
99. Vural P, Akgul C, Yildirim A, Canbaz M. Antioxidant defence in recurrent abortion. Clin Chim Acta. 2000; 295: 169-177.
100. Wouters MG, Boers GH, Blom HJ, Trijbels FJ, Thomas CM, Borm GF. Steegers-Theunissen RP, Eskes TK. Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss. Fertil Steril. 1993; 60: 820-825.
101. Nelen WL, Bulten J, Steegers EA, Blom HJ, Hanselaar AG, Eskes TK. Maternal homocysteine and chorionic vascularization in recurrent early pregnancy loss. Hum Reprod. 2000; 15: 954-960.
102. Agarwal A, Gupta S. Role of reactive oxygen species in female reproduction. Part I. Oxidative stress: a general overview. Women Health. 2005.
103. Riley JC, Behrman HR. Oxygen radicals and reactive oxygen species in reproduction. Proc Soc Exp Biol Med. 1991; 198: 781-791.
104. Angelucci S, Ciavardelli D, Di Giuseppe F, Eleuterio E, Sulpizio M, Tiboni GM, et al. Proteome analysis of human follicular fluid. Biochim Biophys Acta. 2006; 1764: 1775-1785.
105. Bedaiwy MA, Falcone T, Sharma RK, Goldberg JM, Attaran M, Nelson DR, et al. Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial. Hum Reprod. 2002; 17: 426-431.
106. Ho HN, Wu MY, Chen SU, Chao KH, Chen CD, Yang YS. Total antioxidant status and nitric oxide do not increase in peritoneal fluids from women with endometriosis. Hum Reprod. 1997; 12: 2810-2815.
107. Liu Y, Luo L, Zhao H. Levels of lipid peroxides and superoxide dismutase in peritoneal fluid of patients with endometriosis. J Tongji Med Univ. 2001; 21: 166-167.
108. Murphy AA, Palinski W, Rankin S, Morales AJ, Parthasarathy S. Macrophage scavenger receptor(s) and oxidatively modified proteins in endometriosis. Fertil Steril. 1998; 69: 1085-1091.
109. Zeller JM, Henig I, Radwanska E, Dmowski WP. Enhancement of human monocyte and peritoneal macrophage chemiluminescence activities in women with endometriosis. Am J Reprod Immunol Microbiol. 1987; 13: 78-82.
110. Ota H, Igarashi S, Hatazawa J, Tanaka T. Endothelial nitric oxide synthase in the endometrium during the menstrual cycle in patients with endometriosis and adenomyosis. Fertil Steril. 1998; 69: 303-308.
111. Polak G, Koziol-Montewka M, Gogacz M, Blaszkowska I, Kotarski J. Total antioxidant status of peritoneal fluid in infertile women. Eur J Obstet Gynecol Reprod Biol. 2001; 94: 261-263.
112. Mukherjee T, Copperman AB, McCaffrey C, Cook CA, Bustillo M, Obasaju MF. Hydrosalpinx fluid has embryotoxic effects on murine embryogenesis: a case for prophylactic salpingectomy. Fertil Steril. 1996; 66: 851-853.
113. Roberts JE, Clarke HJ, Tulandi T, Tan SL. Effects of hydrosalpingeal fluid on murine embryo development and implantation. J Assist Reprod Genet. 1999; 16: 421-424.
114. Szczepanska M, Kozlik J, Skrzypczak J, Mikolajczyk M. Oxidative stress may be a piece in the endometriosis puzzle. Fertil Steril. 2003; 79: 1288-1293.
115. Wang AW, Zhang H, Ikemoto I, Anderson DJ, Loughlin KR. Reactive oxygen species generation by seminal cells during cryopreservation. Urology. 1997; 49: 921-925.
116. Murphy AA, Palinski W, Rankin S, Morales AJ, Parthasarathy S. Evidence for oxidatively modified lipid-protein complexes in endometrium and endometriosis. Fertil Steril. 1998; 69: 1092-1094.
117. Kao SH, Huang HC, Hsieh RH, Chen SC, Tsai MC, Tzeng CR. Oxidative damage and mitochondrial DNA mutations with endometriosis. Ann N Y Acad Sci. 2005; 1042: 186-194.
118. Foyouzi N, Berkkanoglu M, Arici A, Kwintkiewicz J, Izquierdo D, Duleba AJ. Effects of oxidants and antioxidants on proliferation of endometrial stromal cells. Fertil Steril. 2004; 82 Suppl 3: 1019-1022.
119. Polak G, Koziol-Montewka M, Tarkowski R, Kotarski J. [Peritoneal fluid and plasma 4-hydroxynonenal and malonyldialdehyde concentrations in infertile women]. Ginekol Pol. 2001; 72: 1316-1320.
120. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997; 18: 774-800.
121. Palacio JR, Iborra A, Ulcova-Gallova Z, Badia R, Martinez P. The presence of antibodies to oxidative modified proteins in serum from polycystic ovary syndrome patients. Clin Exp Immunol. 2006; 144: 217-222/
122. Gonzalez F, Rote NS, Minium J, Kirwan JP. Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocrinol Metab. 2006; 91: 336-340.
123. Yilmaz M, Bukan N, Ayvaz G, A Karakoc, Toruner F, Cakir N, et al. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome. Hum Reprod. 2005; 20: 3333-3340.
124. Fenkci V, Fenkci S, Yilmazer M, Serteser M. Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease. Fertil Steril. 2003; 80: 123-127.
125. Sabuncu T, Vural H, Harma M. Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease. Clin Biochem. 2001; 34: 407-413.
126. Dinger Y, Akcay T, Erdem T, Ilker Saygili E, Gundogdu D. DNA damage, DNA susceptibility to oxidation and glutathione level in women with polycystic ovary syndrome. Scand J Clin Lab Invest. 2005; 65: 721-728.
127. Pasqualotto EB, Agarwal A, Sharma RK, Izzo VM, Pinotti JA, et al. Effect of oxidative stress in follicular fluid on the outcome of assisted reproductive procedures. Fertil Steril. 2004; 81: 973-976.
128. Attaran M, Pasqualotto E, Falcone T, Goldberg JM, Miller KF, Agarwal A, et al. The effect of follicular fluid reactive oxygen species on the outcome of in vitro fertilization. Int J Fertil Womens Med. 2000; 45: 314-320.
129. Hyslop PA, Hinshaw DB, Halsey WA Jr, Schraufstatter IU, Sauerheber RD, Spragg RG, et al. Mechanisms of oxidant-mediated cell injury. The glycolytic and mitochondrial pathways of ADP phosphorylation are major intracellular targets inactivated by hydrogen peroxide. J Biol Chem. 1988; 263: 1665-1675.
130. Harvey AJ, Kind KL, Thompson JG. REDOX regulation of early embryo development. Reproduction. 2002; 123: 479-486.
131. Das S, Chattopadhyay R, Ghosh S, Ghosh S, Goswami SK, et al. Reactive oxygen species level in follicular fluid - embryo quality marker in IVF? Hum Reprod. 2006; 21: 2403-2407.
132. Oyawoye O, Abdel Gadir A, Garner A, Constantinovici N, Perrett C, Hardiman P. Antioxidants and reactive oxygen species in follicular fluid of women undergoing IVF: relationship to outcome. Hum Reprod. 2003; 18: 2270-2274.
133. Bosco L, Ruvolo G, Morici G, Manno M, Cittadini E, Roccheri MC. Apoptosis in human unfertilized oocytes after intracytoplasmic sperm injection. Fertil Steril. 2005; 84: 1417-1423.
134. Paszkowski T, Clarke RN. Antioxidative capacity of preimplantation embryo culture medium declines following the incubation of poor quality embryos. Hum Reprod. 1996; 11: 2493-2495.
135. Bedaiwy MA, Falcone T, Mohamed MS, Aleem AA, Sharma RK, Worley SE, et al. Differential growth of human embryos in vitro: role of reactive oxygen species. Fertil Steril. 2004; 82: 593-600.
136. Bedaiwy M, Agarwal A, Said TM, Goldberg JM, Sharma RK, Worley S, et al. Role of total antioxidant capacity in the differential growth of human embryos in vitro. Fertil Steril. 2006; 86: 304-309.
137. Goto Y, Noda Y, Mori T, Nakano M. Increased generation of reactive oxygen species in embryos cultured in vitro. Free Radic Biol Med. 1993; 15: 69-75.
138. Filler R, Lew KJ. Developmental onset of mixed function oxidase activity in preimplantation mouse embryos. Proc Natl Acad Sci USA. 1981; 78: 6991-6995.
139. Jurisicova A, Varmuza S, Casper RF. Programmed cell death and human embryo fragmentation. Mol Hum Reprod. 1996; 2: 93-98.
140. Beehler BC, Przybyszewski J, Box HB, Kulesz-Martin MF. Formation of 8-hydroxydeoxyguanosine within DNA of mouse keratinocytes exposed in culture to UVB and H2O2. Carcinogenesis. 1992; 13: 2003-2007.
141. Nakayama T, Noda Y, Goto Y, Mori T. Effects of visible light and other environmental factors on the production of oxygen radicals by hamster embryos. Theriogenology. 1994; 41: 499-510.
142. Maas DH, Storey BT, Mastroianni L Jr. Oxygen tension in the oviduct of the rhesus monkey (Macaca mulatta). Fertil Steril. 1976; 27: 1312-1317.
143. Alvarez JG, Storey BT. Evidence for increased lipid peroxidative damage and loss of superoxide dismutase activity as a mode of sublethal cryodamage to human sperm during cryopreservation. J Androl. 1992; 3: 232-241.
144. Lane M, Maybach JM, Gardner K. Addition of ascorbate during cryopreservation stimulates subsequent embryo development. Hum Reprod. 2002; 17: 2686-2693.
145. Ali A, Benkhalifa M, Miron P. In vitro maturation of oocytes: biological aspects. Reprod Biomed Online. 2006; 13: 437-446.
146. Mrazek M, Fulka J Jr. Failure of oocyte maturation: possible mechanisms for oocyte maturation arrest. Hum Reprod. 2003; 18: 2249-2252.
147. Zhang L, Jiang S, Wozniak PJ, Yang X, Godke RA. Cumulus cell function during bovine oocyte maturation, fertilization, and embryo development in vitro. Mol Reprod Dev. 1995; 40: 338-344.
148. Tatemoto H, Sakurai N, Muto N. Protection of porcine oocytes against apoptotic cell death caused by oxidative stress during In vitro maturation: role of cumulus cells. Biol Reprod. 2000; 63: 805-810.
149. Oyamada T, Fukui Y. Oxygen tension and medium supplements for in vitro maturation of bovine oocytes cultured individually in a chemically defined medium. J Reprod Dev. 2004; 50: 107-117.
150. Tao Y, Zhou B, Xia G, Wang F, Wu Z, Fu M. Exposure to L-ascorbic acid or alpha-tocopherol facilitates the development of porcine denuded oocytes from metaphase I to metaphase II and prevents cumulus cells from fragmentation. Reprod Domest Anim. 2004; 39: 52-57.
151. Henkel RR, Schill WB. Sperm preparation for ART. Reprod Biol Endocrinol. 2003; 1: 108.
152. Kattera S, Chen C. Short coincubation of gametes in in vitro fertilization improves implantation and pregnancy rates: a prospective, randomized, controlled study. Fertil Steril. 2003; 80: 1017-1021.
153. Lornage J. Biological aspects of endometriosis in vitro fertilization. J Gynecol Obstet Biol Reprod (Paris). 2003; 32: S48-50.
154. Ebisch IM, Thomas CM, Peters WH, Braat DD, Steegers-Theunissen RP. The importance of folate, zinc and antioxidants in the pathogenesis and prevention of subfertility. Hum Reprod Update. 2007; 13: 163-174.
155. Joshi R, Adhikari S, Patro BS, Chattopadhyay S, Mukherjee T. Free radical scavenging behavior of folic acid: evidence for possible antioxidant activity. Free Radic Biol Med. 2001; 30: 1390-1399.
156. Bentivoglio G, Melica F, Cristoforoni P. Folinic acid in the treatment of human male infertility. Fertil Steril. 1993; 60: 698-701.
157. Szymanski W, Kazdepka-Zieminska A. [Effect of homocysteine concentration in follicular fluid on a degree of oocyte maturity]. Ginekol Pol. 2003; 74: 1392-1396.
158. Zago MP, Oteiza PI. The antioxidant properties of zinc: interactions with iron and antioxidants. Free Radic Biol Med. 2001; 31: 266-274.
159. Saaranen M, Suistomaa U, Kantola M, Saarikoski S, Vanha-Perttula T. Lead, magnesium, selenium and zinc in human seminal fluid: comparison with semen parameters and fertility. Hum Reprod. 1987; 2: 475-479.
160. Shaw NA, Dickey HC, Brugman HH, Blamberg DL, Witter JF. Zinc deficiency in female rabbits. Lab Anim. 1974; 8: 1-7.
161. Ng SC, Karunanithy R, Edirisinghe WR, Roy AC, Wong PC, Ratnam SS. Human follicular fluid levels of calcium, copper and zinc. Gynecol Obstet Invest. 1987; 23: 129-132.
162. Comhaire FH, Christophe AB, Zalata AA, Dhooge WS, Mahmoud AM, Depuydt CE. The effects of combined conventional treatment, oral antioxidants and essential fatty acids on sperm biology in subfertile men. Prostaglandins Leukot Essent Fatty Acids. 2000; 63: 159-165.
163. Kodama H, Yamaguchi R, Fukuda J, Kasai H, Tanaka T. Increased oxidative deoxyribonucleic acid damage in the spermatozoa of infertile male patients. Fertil Steril. 1997; 68: 519-524.
164. Tremellen K, Miari G, Froiland D, Thompson J. A randomised control trial examining the effect of an antioxidant (Menevit) on pregnancy outcome during IVFICSI treatment. Aust N Z J Obstet Gynaecol. 2007; 47: 216-221.
165. Crha I, Hruba D, Ventruba P, Fiala J, Totusek J, Visnova H. Ascorbic acid and infertility treatment. Cent Eur J Public Health. 2003; 11: 63-67.
166. Westphal LM, Polan ML, Trant AS, Mooney SB. A nutritional supplement for improving fertility in women: a pilot study. J Reprod Med. 2004; 49: 289-293.
167. Henmi H, Endo T, Kitajima Y, Manase K, Hata H, Kudo R. Effects of ascorbic acid supplementation on serum progesterone levels in patients with a luteal phase defect. Fertil Steril. 2003; 80: 459-461.
168. Paszkowski T, Clarke RN, Hornstein MD. Smoking induces oxidative stress inside the Graafian follicle. Hum Reprod. 2002; 17: 921-925.
169. Wiener-Megnazi Z, Vardi L, Lissak A, Shnizer S, Reznick AZ, Ishai D, et al. Oxidative stress indices in follicular fluid as measured by the thermochemiluminescence assay correlate with outcome parameters in in vitro fertilization. Fertil Steril. 2004; 82 Suppl 3: 1171-1176.
170. Quinn P, Horstman FC. Is the mouse a good model for the human with respect to the development of the preimplantation embryo in vitro? Hum Reprod. 1998; 13(Suppl 4): 173-183.
171. Okada H, Tatsumi N, Kanzaki M, Fujisawa M, Arakawa S, Kamidono S. Formation of reactive oxygen species by spermatozoa from asthenospermic patients: response to treatment with pentoxifylline. J Urol. 1997; 157: 2140-2146.
172. Lenzi A, Picardo M, Gandini L, Lombardo F, Terminali O, Passi S, et al. Glutathione treatment of dyspermia: effect on the lipoperoxidation process. Hum Reprod. 1994; 9: 2044-2050.
173. Zalata AA, Ahmed AH, Allamaneni SS, Comhaire FH, Agarwal A. Relationship between acrosin activity of human spermatozoa and oxidative stress. Asian J Androl. 2004; 6: 313-318.
174. Twigg J, Irvine DS, Houston P, Fulton N, Michael L, Aitken RJ. Iatrogenic DNA damage induced in human spermatozoa during sperm preparation: protective significance of seminal plasma. Mol Hum Reprod. 1998; 4: 439-445.
175. Esteves SC, Sharma RK, Thomas AJ Jr, Agarwal A. Cryopreservation of human spermatozoa with pentoxifylline improves the post-thaw agonist-induced acrosome reaction rate. Hum Reprod. 1998; 13: 3384-3389.
176. Zhang X, Sharma RK, Agarwal A, Falcone T. Effect of pentoxifylline in reducing oxidative stress-induced embryotoxicity. J Assist Reprod Genet. 2005; 22: 415-417.
177. Nasr-Esfahani M, Johnson MH, Aitken RJ. The effect of iron and iron chelators on the in vitro block to development of the mouse preimplantation embryo: BAT6 a new medium for improved culture of mouse
178. Gardner DK, Lane MW, Lane M. EDTA stimulates cleavage stage bovine embryo development in culture but inhibits blastocyst development and differentiation. Mol Reprod Dev. 2000; 57: 256-261.
179. Nasr-Esfahani MH, Johnson MH. Quantitative analysis of cellular glutathione in early preimplantation mouse embryos developing in vivo and in vitro. Hum Reprod. 1992; 7: 1281-1290.
180. Luvoni GC, Keskintepe L, Brackett BG. Improvement in bovine embryo production in vitro by glutathione containing culture media. Mol Reprod Dev. 1996; 43: 437-443.
181. Tarin JJ, de los Santos MJ, de Oliveira MN, Pellicer A, Bonilla-Musoles F. Ascorbate-supplemented media in short-term cultures of human embryos. Hum Reprod. 1994; 9: 1717-1722.
182. Olson SE, Seidel GE Jr. Culture of in vitro-produced bovine embryos with vitamin E improves development in vitro and after transfer to recipients. Biol Reprod. 2000; 62: 248-252.
183. Wang X, Falcone T, Attaran M, Goldberg JM, Agarwal A, Sharma RK. Vitamin C and vitamin E supplementation reduce oxidative stress-induced embryo toxicity and improve the blastocyst development rate. Fertil Steril. 2002; 78: 1272-1277.
184. Lin TC, Yen JM, Gong KB, Hsu TT, Chen LR. IGF-1/IGFBP-1 increases blastocyst formation and total blastocyst cell number in mouse embryo culture and facilitates the establishment of a stem-cell line. BMC Cell Biol. 2003; 4: 14.
185. Kurzawa R, Glabowski W, Baczkowski T, Brelik P. Evaluation of mouse preimplantation embryos exposed to oxidative stress cultured with insulin-like growth factor I and II, epidermal growth factor, insulin, transferrin and selenium. Reprod Biol. 2002; 2: 143-162.
186. Catt JW, Henman M. Toxic effects of oxygen on human embryo development. Hum Reprod. 2000; 15 Suppl 2: 199-206.